CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

Author(s):
Wissing, M.D.; Coenen, J.L.L.M.; Berg, P. van den; Westgeest, H.M.; Eertwegh, A.J.M. van den; Oort, I.M. van; Bos, M.M.; Bergman, A.M.; Hamberg, P.; Tije, A.J. ten; ; Lolkema, M.P.J.K.; Wit, R. de; Gelderblom, H.
Published
2015
Publication type
Article / Letter to editor
prostate cancercabazitaxelabirateronedocetaxelsequential treatment
Date issued
2015-03-15
Language
English
Is part of
International Journal of Cancer (2015), Vol. 136, no. 6, p. E760-E772
hdl
1887/105189
doi
10.1002/ijc.29231